Open AccessNeoadjuvant Therapy for Pancreatic Malignancy: Paradigm Shifts in Multidisciplinary Care
Author(s) -
Russell C. Langan
Publication year - 2021
Publication title -
archives of surgery and surgical education
Language(s) - English
Resource type - Journals
ISSN - 2689-3126
DOI - 10.24966/asse-3126/100019
Subject(s) - malignancy , pancreatic ductal adenocarcinoma , pancreatic cancer , medicine , multidisciplinary approach , oncology , adenocarcinoma , neoadjuvant therapy , cause of death , cancer , political science , disease , breast cancer , law
Pancreatic Ductal Adenocarcinoma (PDAC) accounts for the third leading cause of cancer death in the United States and portends a poor prognosis, with over five-year survival rates of about ten percent.